COVID-19

Partner Content

Partner Content

New collaboration launched to drive understanding of COVID-1...

Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19

News

Gilead's remdesivir hailed as COVID-19 standard of care afte...

It's official - Gilead's remdesivir helps severely ill patients recover faster from COVID-19, according to results from a phase 3 placebo-controlled trial.

News

Shares in Vertex jump on overnight success of CF triple ther...

Shares in US pharma Vertex were up sharply in premarket trading after its newly-launched cystic fibrosis triple therapy attained blockbuster status almost overnight, leading

Views & Analysis

How AI is fighting COVID-19: the companies using intelligent...

The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.

News

AZ joins COVID-19 vaccine race with Oxford Uni partnership

AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine, ahead of an early trial readout as soon as June or July.

News